Neurodegeneration in amyotrophic lateral sclerosis: The role of oxidative stress and altered homeostasis of metals

Brain Research Bulletin

Volumn 61, Issue 4, 2003, Pages 365-374

  Carrì, Maria Teresa ^a,b   Ferri, Alberto ^b,c   Cozzolino, Mauro ^b   Calabrese, Lilia ^d   Rotilio, Giuseppe ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Ctro Neurbio Mondino Tor V   (Italy)

^c CNR   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Copper; Iron; Neurodegeneration; Oxidative stress; Superoxide dismutase

Indexed keywords

COPPER ION; METAL;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN CORTEX; CADAVER; CELL DEATH; FAMILIAL DISEASE; HEREDITY; HOMEOSTASIS; HUMAN; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SAMPLING; SPINAL CORD MOTONEURON;

EID: 0042165931     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(03)00179-5     Document Type: Review

References (104)

1. Abstracts from the 13th International Symposium on ALS/MND, Amyotroph. Lateral Scler. Other Motor Neuron Disorder 3 (2002) 5 and 25 (2002).
2. Almer G., Guegan C., Teismann P., Naini A., Rosoklija G., Hays A.P., Chen C., Przedborski S. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann. Neurol. 49:2001;176-185.
3. Almer G., Teismann P., Stevic Z., Halaschek-Wiener J., Deecke L., Kostic V., Przedborski S. Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology. 58:2002;1277-1279.
4. Andrus P.K., Fleck T.J., Gurney M.E., Hall E.D. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 71:1998;2041-2048.
5. Beal M.F. Mitochondria and the pathogenesis of ALS. Brain. 123:2000;1291-1292.
6. Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., Brown R.H. Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 42:1997;644-654.
7. Bogdanov M., Brown H.R. Jr., Matson W., Smart R., Hayden D., O'Donnell H., Beal M.F., Cudkowicz M. Increased oxidative damage to DNA in ALS patients. Free Radic. Biol. Med. 29:2000;652-658.
8. Bogdanov M.B., Ramos L.E., Xu Z., Beal M.F. Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis. J. Neurochem. 71:1998;1321-1324.
9. Borthwick G.M., Johnson M.A., Ince P.G., Shaw P.J., Turnbull D.M. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann. Neurol. 46:1999;787-790.
10. Brown R.H. Jr. SOD1 aggregates in ALS: cause, correlate or consequence? Nat. Med. 4:1998;1362-1364.
11. Brown D.R., Wong B.S., Hafiz F., Clive C., Haswell S., Jones I.M. Normal prion protein has an activity like that of superoxide dismutase. Biochem. J. 344:1999;1-5.
12. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild type SOD1. Science. 281:1998;1851-1854.
13. Carrì M.T., Battistoni A., Polizio F., Desideri A., Rotilio G. Impaired copper binding by the H46R mutant of human Cu,Zn superoxide dismutase, involved in amyotrophic lateral sclerosis. FEBS Lett. 356:1994;314-316.
14. Casciati A., Ferri A., Cozzolino M., Celsi F., Nencini M., Rotilio G., Carrì M.T. Oxidative modulation of nuclear factor-kappaB in human cells expressing mutant fALS-typical superoxide dismutases. J. Neurochem. 83:2002;1019-1029.
15. Cha C.I., Chung Y.H., Shin C.M., Shin D.H., Kim Y.S., Gurney M.E., Lee K.W. Immunocytochemical study on the distribution of nitrotyrosine in the brain of the transgenic mice expressing a human Cu/Zn SOD mutation. Brain Res. 853:2000;156-161.
16. Ciriolo M.R., De Martino A., Lafavia E., Rossi L., Carrì M.T., Rotilio G. Cu,Zn superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells. J. Biol. Chem. 275:2000;5065-5072.
17. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2:2001;806-819.
18. Corson L.B., Strain J.J., Culotta V.C., Cleveland D.W. Chaperone-facilitated copper binding is a property common to several classes of familial amyiotrophic lateral sclerosis-linked superoxide dismutase mutants. Proc. Natl. Acad. Sci. U.S.A. 95:1998;6361-6366.
19. Curti D., Malaspina A., Facchetti G., Camana C., Mazzini L., Tosca P., Zerbi F., Ceroni M. Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology. 47:1996;1060-1064.
20. De Freitas J.M., Liba A., Meneghini R., Valentine J.S., Gralla E.B. Yeast lacking Cu-Zn superoxide dismutase show altered iron homeostasis. Role of oxidative stress in iron metabolism. J. Biol. Chem. 275:2000;11645-11649.
21. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., Warner C., Deng G., Soriano E., Smyth C., Parge H.E., Ahmed A., Roses A.D., Hallewell R.A., Pericak-Vance M.A., Siddique T. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 261:1993;1047-1051.
22. Dhaliwal G.K., Grewal R.P. Mitochondrial DNA deletion mutation levels are elevated in ALS brains. Neuroreport. 11:2000;2507-2509.
23. Drachman D.B., Frank K., Dykes-Hoberg M., Teismann P., Almer G., Przedborski S., Rothstein J.D. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 52:2002;771-778.
24. Elliott J.L. Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res. Mol. Brain Res. 95:2001;172-178.
25. Ferrante R.J., Browne S.E., Shinobu L.A., Bowling A.C., Baik M.J., MacGarvey U., Kowall N.W., Brown R.H. Jr., Beal M.F. Evidence of increased oxidative damage in both sporadic and FALS. J. Neurochem. 69:1997;2064-2074.
26. Ferri A., Gabbianelli R., Casciati A., Celsi F., Rotilio G., Carrì M.T. Oxidative inactivation of calcineurin by Cu,Zn superoxide dismutase G93A, a mutant typical of familial amyotrophic lateral sclerosis. J. Neurochem. 79:2001;531-538.
27. Fitzmaurice P.S., Shaw I.C., Kleiner H.E., Miller R.T., Monks T.J., Lau S.S., Mitchell J.D., Lynch P.G. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve. 19:1996;797-798.
28. Fleming R.E., Migas M.C., Zhou X., Jiang J., Britton R.S., Brunt E.M., Tomatsu S., Waheed A., Bacon B.R., Sly W.S. Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. Proc. Natl. Acad. Sci. U.S.A. 96:1999;3143-3148.
29. Fleury C., Mignotte B., Vayssiere J.L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie. 84:2002;131-141.
30. Fujita K., Yamauchi M., Shibayama K., Ando M., Honda M., Nagata Y. Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis. J. Neurosci. Res. 45:1996;276-281.
31. Gabbianelli R., Ferri A., Rotilio G., Carrì M.T. Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis. J. Neurochem. 73:1999;1175-1180.
32. Ghadge G.D., Lee J.P., Bindokas V.P., Jordan J., Ma L., Miller R.J., Roos R.P. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. 17:1997;8756-8766.
33. Gong Y.H., Elliott J.L. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis. Exp. Neurol. 162:2000;27-36.
34. Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. 20:2000;660-665.
35. Guegan C., Vila M., Rosoklija G., Hays A.P., Przedborski S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci. 21:2001;6569-6576.
36. Gurney M.E., Cutting F.B., Zhai P., Doble A., Taylor C.P., Andrus P.K., Hall E.D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;147-157.
37. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., Chen W., Zhai P., Sufit R., Siddique T. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264:1994;1772-1775.
38. Hall E.D., Andrus P.K., Oostveen J.A., Fleck T.J., Gurney M.E. Relationship of oxygen radical-induced lipid peroxidative damage to disease onset and progression in transgenic model of familial ALS. J. Neurosci. Res. 53:1998;66-77.
39. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
40. Hand C.K., Rouleau G.A. Familial amyotrophic lateral sclerosis. Muscle Nerve. 25:2002;135-159.
41. Harris Z.L., Klomp L.W.J., Gitlin J.D. Aceruplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am. J. Clin. Nutr. 67:1998;972S-9767S.
42. Hayward L.J., Rodriguez J.A., Kim J.W., Tiwari A., Goto J.J., Cabelli D.E., Valentine J.S., Brown R.H. Jr. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial ALS. J. Biol. Chem. 277:2002;15923-15931.
43. Heath P.R., Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve. 26:2002;438-458.
44. Higgins C.M., Jung C., Ding H., Xu Z. Mutant Cu,Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J. Neurosci. 22:2002;RC215.
45. Ho B.K., Alexianu M.E., Colom L.V., Serrano F., Appel S.H. Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6796-6801.
46. Hottinger A.F., Fine E.G., Gurney M.E., Zurn A.D., Aebscher P. The copper chelator D-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur. J. Neurosci. 9:1997;1548-1551.
47. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., Bush A.I. The amyloid-β-peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry. 38:1999;7609-7916.
48. Julien J.-P. Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell. 104:2001;581-591.
49. Jung C., Higgins C.M., Xu Z. Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J. Neurochem. 83:2002;535-545.
50. Kasarskis E.J., Tandon L., Lovell M.A., Ehmann W.D. Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study. J. Neurol. Sci. 130:1995;203-208.
51. L.C. Kuhn, Control of cellular iron transport and storage at the molecular level, in: L. Hallberg, N.-G. Asp (Eds.), Iron Nutrition in Health and Disease, John Libbey & Company Ltd., London, 1996.
52. Lee J.P., Gerin C., Bindokas V.P., Miller R., Ghadge G., Roos R.P. No correlation between aggregates of Cu/Zn superoxide dismutase and cell death in familial amyotrophic lateral sclerosis. J. Neurochem. 82:2002;1229-1238.
53. Lin E., Graziano J.H., Freyer G.A. Regulation of the 75-kDa subunit of mitochondrial complex I by iron. J. Biol. Chem. 276:2001;27685-27692.
54. Lindenau J., Noack H., Possel H., Asayama K., Wolf G. Cellular distribution of superoxide dismutases in the rat CNS. Glia. 29:2000;25-34.
55. Lino M.M., Schneider C., Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 22:2002;4825-4832.
56. - in the production of HO·: in vitro and in vivo. Free Radic. Biol. Med. 16:1994;29-33.
57. Liu R., Althaus J.S., Ellerbrock B.R., Becker D.A., Gurney M.E. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis. Ann. Neurol. 44:1998;763-770.
58. Liu D., Wen J., Liu J., Li L. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J. 13:1999;2318-2328.
59. Martin L.J. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol. 58:1999;459-471.
60. Mattiazzi M., D'Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., Manfredi G. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 277:2002;29626-29633.
61. Menzies F.M., Cookson M.R., Taylor R.W., Turnbull D.M., Chrzanowska-Lightowlers Z.M., Dong L., Figlewicz D.A., Shaw P.J. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain. 125:2002;1522-1533.
62. Migheli A., Piva R., Attori C., Troost D., Schiffer D. c-Jun, JNK/SAPK kinases and transcription factor NF-kappa B are selectively activated in astrocytes, but not motor neurons, in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 56:1997;1314-1322.
63. Nagano S., Satoh M., Sumi H., Fujimura H., Tohyama C., Yanagihara T., Sakoda S. Reduction of metallothioneins promotes the disease expression of familial amyotrophic lateral sclerosis mice in a dose-dependent manner. Eur. J. Neurosci. 13:2001;1363-1370.
64. Nakano Y., Hirayama K., Terao K. Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral sclerosis. Arch. Neurol. 44:1987;103-106.
65. Olsen M.K., Roberds S.L., Ellerbrock B.R., Fleck T.J., McKinley D.K., Gurney M.E. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann. Neurol. 50:2001;730-740.
66. Orrell R.W. Amyotrophic lateral sclerosis: copper/zinc superoxide dismutase (SOD1) gene mutations. Neuromuscul. Disord. 10:2000;63-68.
67. Pardo C.A., Xu Z., Borchelt D.R., Price D.L., Sisodia S.S., Cleveland D.W. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. U.S.A. 92:1995;954-958.
68. Patel B.N., Dunn R.J., Jeong S.H., Zhu Q., Julien J.-P., David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22:2002;6578-6586.
69. Petrovic N., Comi A., Ettinger M.J. Identification of an apo-superoxide dismutase pool in human lymphoblasts. J. Biol. Chem. 271:1996;28331-28334.
70. Poligone B., Baldwin A.S. Positive and negative regulation of NF-κB by Cox2. J. Biol. Chem. 276:2001;38658-38664.
71. Pramatarova A., Laganiere J., Roussel J., Brisebois K., Rouleau G.A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21:2001;3369-3374.
72. Puig S., Thiele D.J. Molecular mechanisms of copper uptake and distribution. Curr. Opin. Chem. Biol. 6:2002;171-180.
73. Puttaparthi K., Gitomer W.L., Krishnan U., Son M., Rajendran B., Elliot J.L. Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J. Neurosci. 22:2002;8790-8796.
74. Rae T.D., Schmidt P.J., Pufahl R.A., Culotta V.C., O'Halloran T.V. Undetectable intracellular copper: the requirement of a copper chaperone for superoxide dismutase. Science. 284:1999;805-808.
75. Raoul C., Estevez A.G., Nishimune H., Cleveland D.W., deLapeyriere O., Henderson C.E., Haase G., Pettmann B. Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron. 35:2002;1067-1083.
76. Rizzardini M., Lupi M., Bernasconi S., Mangolini A., Cantoni L. Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid. J. Neurol. Sci. 207:2003;51-58.
77. Robertson J., Kriz J., Nguyen M.N., Julien J.P. Pathways to motor neuron degeneration in transgenic mouse models. Biochimie. 84:2002;1151-1160.
78. Rodriguez J.A., Valentine J.S., Eggers D.K., Roe J.A., Tiwari A., Brown R.H. Jr., Hayward L.J. Familial ALS-associated mutations decrease the thermal stability of distinctly metallated species of human copper-zinc superoxide dismutase. J. Biol. Chem. 277:2002;15932-15937.
79. Roe J.A., Wiedau-Pazos M., Moy V.N., Goto J.J., Gralla E.B., Valentine J.S. In vivo peroxidative activity of FALS-mutant human Cu,Zn SODs expressed in yeast. Free Radic. Biol. Med. 32:2002;169-174.
80. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X.et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
81. Rowland L.P., Shneider N.A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 344:2001;1688-1700.
82. Said Ahmed M., Hung W.Y., Zu J.S., Hockberger P., Siddique T. Increased reactive oxygen species in familial amyotrophic lateral sclerosis with mutations in SOD1. J. Neurol. Sci. 176:2000;88-94.
83. Shaw P.J., Ince P.G., Falkous G., Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann. Neurol. 38:1995;691-695.
84. Shibata N., Nagai R., Uchida K., Horiuchi S., Yamada S., Hirano A., Kawaguchi M., Yamamoto T., Sasaki S., Kobayashi M. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res. 917:2001;97-104.
85. Shinder G.A., Lacourse M.C., Minotti S., Durham H.D. Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 276:2001;12791-12796.
86. Sillevis-Smitt P.A., Blaauwgeers H.G., Troost D., de Jong J.M. Metallothionein immunoreactivity is increased in the spinal cord of patients with amyotrophic lateral sclerosis. Neurosci. Lett. 144:1992;107-110.
87. Srinivasan C., Liba A., Imlay J.A., Valentine J.S., Gralla E.B. Yeast lacking superoxide dismutase(s) show elevated levels of "free iron" as measured by whole cell electron paramagnetic resonance. J. Biol. Chem. 275:2000;29187-29192.
88. Steinkuhler C., Carrì M.T., Micheli G., Knoepfel L., Weser U., Rotilio G. Copper-dependent metabolism of Cu,Zn superoxide dismutase in human K562 cells. Lack of specific transcriptional activation and accumulation of a partially inactivated enzyme. Biochem. J. 302:1994;687-694.
89. Steinkhuler C., Sapora O., Carrì M.T., Nagel W., Marcocci L., Ciriolo M.R., Weser U., Rotilio G. Increase of Cu,Zn-superoxide dismutase activity during differentiation of human K562 cells involves activation by copper of a constantly expressed copper-deficient protein. J. Biol. Chem. 266:1991;24580-24587.
90. Subramaniam J.R., Lyons W.E., Liu J., Bartnikas T.B., Rothstein J., Proce D.L., Cleveland D.L., Gitlin J.D., Wong P. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nat. Neurosci. 5:2002;301-307.
91. Swerdlow R.H., Parks J.K., Cassarino D.S., Trimmer P.A., Miller S.W., Maguire D.J., Sheehan J.P., Maguire R.S., Pattee G., Juel V.C., Phillips L.H., Tuttle J.B., Bennett J.P. Jr., Davis R.E., Parker W.D. Jr. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp. Neurol. 153:1998;135-142.
92. Takeuchi H., Kobayashi Y., Ishigaki S., Doyu M., Sobue G. Mitochondrial localization of mutant superoxide dismutase 1 triggers caspase-dependent cell death in a cellular model of familial amyotrophic lateral sclerosis. J. Biol. Chem. 277:2002;50966-50972.
93. Taylor B.S., de Vera M.E., Ganster R.W., Wang Q., Shapiro R.A., Morris S.M. Jr., Billiar T.R., Geller D.A. Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273:1998;15148-15156.
94. Thomson A.M., Rogers J.T., Leedman P.J. Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. Int. J. Biochem. Cell Biol. 31:1999;1139-1152.
95. Tiwari A., Hayward L.J. Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction. J. Biol. Chem. 278:2003;5984-5992.
96. Torsdottir G., Kristinsson J., Gudmundsson G., Snaedal J., Johannesson T. Copper, ceruloplasmin and superoxide dismutase (SOD) on amyotrophic lateral sclerosis. Pharmacol. Toxicol. 87:2000;126-130.
97. Urushitani M., Kurisu J., Tsukita K., Takahashi R. Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in FALS. J. Neurochem. 83:2002;1030-1042.
98. Valentine J.S. Do oxidatively modified proteins cause ALS? Free Radic. Biol. Med. 33:2002;1314-1320.
99. Volkel H., Scholz M., Link J., Selzle M., Werner P., Tunnemann R., Jung G., Ludolph A.C., Reuter A. Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin. FEBS Lett. 503:2001;201-205.
100. Wiedau-Pazos M., Goto J.J., Rabizadeh S., Gralla E.B., Roe J.A., Lee M.K., Valentine J.S., Bredesen D.E. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-518.
101. Wiedemann F.R., Manfredi G., Mawrin C., Beal M.F., Schon E.A. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem. 80:2002;616-625.
102. Yim M.B., Kang J.-H., Yim H.-S., Kwak H.-S., Chock P.B., Stadtman E.R. A gain of function of an amyotrophic lateral sclerosis associated Cu,Zn superoxide dismutase mutant: enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5709-5714.
103. Yoshihara T., Ishigaki S., Yamamoto M., Liang Y., Niwa J., Takeuchi H., Doyu M., Sobue G. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 80:2002;158-167.
104. Zhang H., Joseph J., Gurney M., Becker D., Kalyanaraman B. Bicarbonate enhances peroxidase activity of Cu,Zn-superoxide dismutase. Role of carbonate anion radical and scavenging of carbonate anion radical by metalloporphyrin antioxidant enzyme mimetics. J. Biol. Chem. 277:2002;1013-1020.